4 results match your criteria: "China Medical University the Fourth People's Hospital of Shenyang[Affiliation]"
Clin Ophthalmol
September 2024
Department of Ophthalmology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Pediatr Dermatol
November 2024
Department of Dermatology, The First Hospital of China Medical University, Shenyang, China.
Clin Ophthalmol
November 2023
Department of Ophthalmology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Objective: To assess the functional and anatomical effects of transitioning to conbercept intravitreal injection (IVC) treatment in patients with diabetic macular edema (DME) who had inadequate responses to prior anti-vascular endothelial growth factor (anti-VEGF) injections.
Methods: We retrospectively included eyes with persistent DME after at least 3 injections of intravitreal ranibizumab (IVR). The analysis included the assessment of best corrected visual acuity (BCVA) and central macular thickness (CMT) during 6 months after the switch.
BMC Neurosci
November 2022
Department of Ophthalmology, China Medical University the Fourth People's Hospital of Shenyang, No.20 Huang He Street, Huang Gu District, Shenyang City, 110031, Liaoning Province, China.
Background: Retinal ganglion cells (RGCs) are important retinal neurons that connect visual receptors to the brain, and lysine-specific demethylase 1 (LSD1) is implicated in the development of RGCs. This study expounded the mechanism of LSD1 in oxygen-glucose deprivation/reoxygenation (OGD/R)-induced pyroptosis of RGCs.
Methods: Mouse RGCs underwent OGD/R exposure, and then RGC viability was examined using the cell counting kit-8 method.